About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Duodenal Exclusion for the Treatment of T2DM | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT00456352

Duodenal Exclusion for the Treatment of T2DM

Evaluation of duodenal exclusion procedure for the treatment of T2DM

Lead sponsor: Medtronic - MITG•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Medtronic - MITG

Age

20 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Age between 20 and 65 years
•2. BMI between 23 and 34
•3. Oral agents or insulin to control T2DM
•4. Inadequate control of diabetes as defined as HbA1c \>/ 7.5
•5. Understanding of the mechanisms of action of the treatment

Exclusion Criteria

•1. More than 10 years of T2DM diagnosis
•2. More than 7 years of insulin use
•3. Previous abdominal operations
•4. Coagulopathy
•5. Liver cirrhosis
•6. Unable to comply with study requirements, follow-up schedule or give valid consent.
•7. Currently pregnant.

Related studies

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

NCT07659535 · Type 2 Diabetes

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)

NCT07102043 · Cystic Fibrosis Related Diabetes

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 22, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment37

Start dateApr 2007

Last updatedAug 22, 2014

Condition

Locations shown

Hospital São Camilo

São Paulo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 22, 2014Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions